A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Mutations in the DAX1 gene cause X-linked adrenal hypoplasia congenita (AHC) and hypogonadotropic hypogonadism (HHG). In affected boys, primary adrenal insufficiency occurs soon after birth or during early childhood; HHG is recognized at the expected time of puberty. In this report, we describe the novel phenotype of a man who presented with apparently isolated adrenal insufficiency at 28 years of age. Examination revealed partial pubertal development and undiagnosed incomplete HHG. Gonadotropin therapy did not improve his marked oligospermia, suggesting a concomitant primary testicular abnormality. Genomic analysis revealed a novel missense mutation, I439S, in DAX1. The mutant DAX-1 protein was studied for its ability to function as a transcriptional repressor of target genes. Consistent with the patient's mild clinical phenotype, the I439S mutation conferred intermediate levels of repressor activity of DAX-1 when compared with mutations associated with classic AHC. This unique case extends the clinical spectrum of AHC to include delayed-onset primary adrenal insufficiency in adulthood and milder forms of HHG. Furthermore, in accordance with findings in Ahch (Dax1) knockout mice, the clinical features in this patient suggest that DAX-1 function is required for spermatogenesis in humans, independent of its known effects on gonadotropin production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of dimeric inhibin B throughout the human menstrual cycle
Groome, N. P. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.4.1401 · Cited by 946 · cited 1×
“Serum inhibin B was measured as described previously (14).”
MethodCluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection
Veldhuis, J. D., & Johnson, M. L. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.250.4.e486 · Cited by 861 · cited 1×
“LH and FAS pulsatility was determined using cluster analysis (method number 7)(15).”
MethodZanaria, E., Muscatelli, F., Bardoni, B., Strom, T. M., Guioli, S., Guo, W., Lalli, E., Moser, C., Walker, A. P., McCabe, E. R. B., et al. (1994) · Nature · doi:10.1038/372635a0 · Cited by 858 · cited 4×
“Discussion The discovery that mutations in the human nuclear receptor gene DAX1 give rise to both X-linked AHC and HHG (1, 11) has provided new insight into the pathogenesis of this syndrome.”
BackgroundInfluentialMuscatelli, F., Strom, T. M., Walker, A. P., Zanaria, E., Récan, D., Meindl, A., Bardoni, B., Guioli, S., Zehetner, G., Rabl, W., et al. (1994) · Nature · doi:10.1038/372672a0 · Cited by 767 · cited 8×
“Mutations in the DAX1 gene in humans cause the Xlinked cytomegalic form of adrenal hypoplasia congenita (AHC), a rare disorder characterized by impaired development of the permanent zone of the adrenal cortex and hypogonadotropic hypogonadism (HHG) (1, 11).”
BackgroundMethodInfluentialSteroidogenic factor 1: a key determinant of endocrine development and function
Parker, K. L., & Schimmer, B. P. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0301 · Cited by 764 · cited 2×
“The coexpression of DAX-1 with SF-1 in the gonadal and adrenal axes (2, 3), and the adrenal failure seen in patients with mutations in these genes (11, 42), suggest that DAX-1 and SF-1 interact in a common genetic pathway.”
BackgroundAchermann, J. C., Ito, M., Ito, M., Hindmarsh, P. C., & Jameson, J. L. (1999) · Nature Genetics · doi:10.1038/9629 · Cited by 709 · cited 1×
“The coexpression of DAX-1 with SF-1 in the gonadal and adrenal axes (2, 3), and the adrenal failure seen in patients with mutations in these genes (11, 42), suggest that DAX-1 and SF-1 interact in a common genetic pathway.”
BackgroundSelf-citationA dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal
Bardoni, B., Zanaria, E., Guioli, S., Floridia, G., Worley, K. C., Tonini, G., Ferrante, E., Chiumello, G., McCabe, E. R. B., Fraccaro, M., et al. (1994) · Nature Genetics · doi:10.1038/ng0894-497 · Cited by 610
Wilms’ tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression.
Nachtigal, M. W., Hirokawa, Y., Enyeart-VanHouten, D. L., Flanagan, J. N., Hammer, G. D., & Ingraham, H. A. (1998) · Cell · doi:10.1016/s0092-8674(00)81172-1 · Cited by 591
Dax1 antagonizes Sry action in mammalian sex determination
Swain, A., Narvaez, V., Burgoyne, P., Camerino, G., & Lovell-Badge, R. (1998) · Nature · doi:10.1038/35799 · Cited by 550 · cited 1×
“This repression is compatible with the XY sex reversal seen in association with overexpression of Ahch/Dax1 in mice (45) and humans (46), where DAX-1 is thought to antagonize the actions of the testis-determination factor, SRY, in gonadal development.”
BackgroundA Dosage Sensitive Locus at Chromosome Xp21 Is Involved in Male to Female Sex Reversal
Bardoni, B., Zanaria, E., Guioli, S., Floridia, G., Worley, K. C., Tonini, G., Ferrante, E., Chiumello, G., McCabe, E. R. B., Fraccaro, M., et al. (1995) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199502000-00020 · Cited by 539 · cited 1×
“This repression is compatible with the XY sex reversal seen in association with overexpression of Ahch/Dax1 in mice (45) and humans (46), where DAX-1 is thought to antagonize the actions of the testis-determination factor, SRY, in gonadal development.”
Background
Research works printed but not linked: 1
- Reutens, A.T., et al. 1999. Clinical and functional effects of mutations in the DAX1 gene in patients with adrenal hypoplasia congenita. J. Clin. Endocrinol. Metab. 84 :504-511.
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
10.1016/b978-1-4160-2911-3.50026-1
(2000) · CrossRef Listing of Deleted DOIs · doi:10.1016/b978-1-4160-2911-3.50026-1 · Cited by 554
Beranova, M., Oliveira, L. M. B., Bédécarrats, G. Y., Schipani, E., Vallejo, M., Ammini, A. C., Quintos, J. B., Hall, J. E., Martin, K. A., Hayes, F. J., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7395 · Cited by 216
DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease
Suntharalingham, J. P., Buonocore, F., Duncan, A. J., & Achermann, J. C. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.07.004 · Cited by 231
Self-citationLin, L., Gu, W.-X., Ozisik, G., To, W. S., Owen, C. J., Jameson, J. L., & Achermann, J. C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0603 · Cited by 210
“It also seems likely that an intrinsic defect in spermatogenesis, which may be present in humans as well as mice, results in a worse fertility prognosis for individuals with X-linked AHC compared with young men with isolated idiopathic HH (8, 19, 20).”
BackgroundSelf-citationA systematic review and standardized clinical validity assessment of male infertility genes
Oud, M. S., Volozonoka, L., Smits, R. M., Vissers, L. E. L. M., Ramos, L., & Veltman, J. A. (2019) · Human Reproduction · doi:10.1093/humrep/dez022 · Cited by 208
Lalli, E., & Sassone-Corsi, P. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0159 · Cited by 169
“This is diagnosed in AHC patients in whom appropriate hormonal replacement therapy allows survival beyond pubertal age and is caused by combined hypothalamic failure in GnRH Abbreviations: AHC, Adrenal hypoplasia congenita; dpc, days post coitus; DSS, dosage-sensitive sex reversal; HHG, hypogonadotropic hypogonadism;…”
BackgroundInfluentialMolecular aspects of steroidogenic factor 1 (SF-1)
Hoivik, E. A., Lewis, A. E., Aumo, L., & Bakke, M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.07.003 · Cited by 168
Phenotypic spectrum of mutations in DAX-1 and SF-1
Achermann, J. C., Meeks, J. J., & Larry Jameson, J. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00619-0 · Cited by 163
Self-citationMaione, L., Dwyer, A. A., Francou, B., Guiochon‐Mantel, A., Binart, N., Bouligand, J., & Young, J. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0749 · Cited by 161
Fetal Leydig Cell Origin and Development
Griswold, S. L., & Behringer, R. R. (2009) · Sexual Development · doi:10.1159/000200077 · Cited by 169
“Dax1 (Nr0b1) encodes an Xlinked nuclear receptor that acts as a transcriptional antagonist to SF-1 in vitro (Zazopoulos et al., 1997; Lalli et al., 1998; Nachtigal et al., 1998; Tabarin et al., 2000; Wang et al., 2001; Salvi et al., 2002; Suzuki et al., 2003).”
BackgroundAromatase ( Cyp19 ) expression is up-regulated by targeted disruption of Dax1
Wang, Z. J., Jeffs, B., Ito, M., Achermann, J. C., Yu, R. N., Hales, D. B., & Jameson, J. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141543298 · Cited by 138
Self-citationMutations inNR0B1 (DAX1) andNR5A1 (SF1) responsible for adrenal hypoplasia congenita
Phelan, J. K., & Mccabe, E. R. B. (2001) · Human Mutation · doi:10.1002/humu.1225 · Cited by 110
“Additionally, defects in sperm production [Schwartz et al., 1997; Seminara et al., 1999; Tabarin et al., 2000], and testicular morphology and physiology [Caron et al.”
BackgroundInfluentialÖzışık, G., Mantovani, G., Achermann, J. C., Persani, L., Spada, A., Weiss, J., Beck‐Peccoz, P., & Jameson, J. L. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021034 · Cited by 107
“Recently, an adult-onset form of AHC has been described in two patients who have missense mutations in the putative LBD of DAX1 (9, 10).”
BackgroundMethodSelf-citationTremblay, J. J., & Viger, R. S. (2001) · Biology of Reproduction · doi:10.1095/biolreprod64.4.1191 · Cited by 107
Mantovani, G., Özışık, G., Achermann, J. C., Romoli, R., Borretta, G., Persani, L., Spada, A., Jameson, J. L., & Beck‐Peccoz, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8163 · Cited by 101
“The effect of the Y380D mutation on basal transcriptional activity by DAX-1 was investigated using a modified mammalian two-hybrid system (8, 13).”
BackgroundMethodSelf-citationInherited disorders of the gonadotropin hormones
Achermann, J. C., Weiss, J., Lee, E. J., & Jameson, J. L. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00474-9 · Cited by 104
Self-citationHypogonadotropic hypogonadism in subjects with DAX1 mutations
Jadhav, U., Harris, R. M., & Jameson, J. L. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.04.017 · Cited by 103
“He presented with isolated adrenal insufficiency and undiagnosed partial HHG, as there was sufficient testosterone to produce some masculinization at puberty (Tabarin et al., 2000).”
Self-citationGenetic Causes of Human Reproductive Disease
Achermann, J. C. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2447 · Cited by 95
“Limited data from patients with X-linked AHC suggest that DAX1 is involved in spermatogenesis in humans too, and the response to gonadotropin therapy is usually ineffective (54, 55).”
BackgroundSelf-citationPark, S. Y., Meeks, J. J., Raverot, G., Pfaff, L. E., Weiss, J., Hammer, G. D., & Jameson, J. L. (2005) · Development · doi:10.1242/dev.01826 · Cited by 95
“…thereby inhibiting the expression of Sf1-regulated genes such as Star, Dax1, Lhb, 3βHSD (Hsd3b – Mouse Genome Informatics), Cyp19, Cyp11a1 and Amh (Lalli et al., 1998; Nachtigal et al., 1998; Salvi et al., 2002; Suzuki et al., 2003; Tabarin et al., 2000; Wang et al., 2001; Zazopoulos et al., 1997).”
Self-citationPrimary adrenal insufficiency: New genetic causes and their long‐term consequences
Buonocore, F., & Achermann, J. C. (2019) · Clinical Endocrinology · doi:10.1111/cen.14109 · Cited by 101
Self-citationDomenice, S., Latronico, A. C., Brito, V. N., Arnhold, I. J. P., Kok, F., & Mendonca, B. B. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7816 · Cited by 89
“Recently, a unique case extended the clinical spectrum of the disease, including mild forms of hypogonadotropic hypogonadism, delayed-onset of adrenal insufficiency, and abnormal spermatogenesis (17).”
BackgroundAchermann, J. C., Ito, M., Silverman, B. L., Habiby, R. L., Pang, S., Rosler, A., & Jameson, J. L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7660 · Cited by 73
“The effects of DAX-1 and its mutants on basal transcriptional activity were investigated using a modified mammalian two-hybrid system (8, 9).”
BackgroundMethodSelf-citationJeffs, B., Meeks, J. J., Ito, M., Martinson, F. A., Matzuk, M. M., Jameson, J. L., & Russell, L. D. (2001) · Endocrinology · doi:10.1210/endo.142.10.8447 · Cited by 78
“been induced (10, 11), and only rare spermatogonia have”
BackgroundSelf-citationEvidence of Adrenal Failure in Aging Dax1-Deficient Mice
Scheys, J. O., Heaton, J. H., & Hammer, G. D. (2011) · Endocrinology · doi:10.1210/en.2010-0986 · Cited by 78
Monogenic Disorders of Puberty
Kalantaridou, S. N. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2481 · Cited by 65
Presymptomatic diagnosis of X-linked adrenal hypoplasia congenita by analysis of DAX1
Achermann, J. C., Silverman, B. L., Habiby, R. L., & Jameson, J. L. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.108567 · Cited by 59
Self-citationPituitary Physiology and Diagnostic Evaluation
Melmed, S. K., Kleinberg, D. L., & Ho, K. K. Y. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00008-0 · Cited by 64
Molecular pathogenesis of lipoid adrenal hyperplasia and adrenal hypoplasia congenita
Fujieda, K., Okuhara, K., Abe, S., Tajima, T., Mukai, T., & Nakae, J. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00232-2 · Cited by 60
Physiology and Disorders of Puberty
Styne, D. M., & Grumbach, M. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00025-3 · Cited by 65
Frapsauce, C., Ravel, C., Legendre, M., Sibony, M., Mandelbaum, J., Donadille, B., Achermann, J. C., Siffroi, J. P., & Christin-Maitre, S. (2011) · Human Reproduction · doi:10.1093/humrep/deq372 · Cited by 53
“Gonadal defects in men carrying DAX1 mutations have been described in several cases (Caron et al., 1999; Tabarin et al., 2000; Achermann et al., 2001; Mantovani et al., 2002).”
BackgroundSelf-citationLehmann, S. G., Lalli, E., & Sassone‐Corsi, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122044099 · Cited by 53
Current Insights Into Adrenal Insufficiency in the Newborn and Young Infant
Buonocore, F., McGlacken-Byrne, S. M., del Valle, I., & Achermann, J. C. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.619041 · Cited by 57
Self-citationSarfati, J., Dodé, C., & Young, J. (2010) · Frontiers of hormone research · doi:10.1159/000312698 · Cited by 58
Clinical Manifestations of Impaired GnRH Neuron Development and Function
Kim, H.-G., Bhagavath, B., & Layman, L. C. (2008) · Neurosignals · doi:10.1159/000111561 · Cited by 52
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
DAX1 and X-linked adrenal hypoplasia congenita: clinical and molecular analysis in five patients
Mantovani, G., Menis, E. D., Borretta, G., Radetti, G., Bondioni, S., Spada, A., Persani, L., & Beck‐Peccoz, P. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02132 · Cited by 49
DAX1 and its network partners: exploring complexity in development
Clipsham, R. C., & McCabe, E. R. B. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.08.023 · Cited by 57
Molecular Basis of Adrenal Insufficiency
Fujieda, K., & Tajima, T. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000159568.31749.4d · Cited by 51
“These findings are consistent with other reports (41,42).”
BackgroundResultUlloa‐Aguirre, A., Janovick, J. A., Leaños-Miranda, A., & Conn, P. M. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh015 · Cited by 52
“Another X-linked inherited disease that results in congenital adrenal hypoplasia and HH arises from defects in the DAX-1 gene, which encodes a member of the nuclear hormone receptor superfamily (Muscatelli et al., 1994; Habiby et al., 1996; Seminara et al., 1999; Tabarin et al., 2000).”
BackgroundRole of DAX-1 (NR0B1) and Steroidogenic Factor-1 (NR5A1) in Human Adrenal Function
El-Khairi, R., Martinez-Aguayo, A., Ferraz-de-Souza, B., Lin, L., & Achermann, J. C. (2011) · Endocrine Development · doi:10.1159/000321213 · Cited by 48
Self-citationLehmann, S. G. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg108 · Cited by 48
“This mutation produces only a partial impairment of nuclear localization of the DAX-1 protein and incomplete loss of its transcriptional repression activity ( 21 ).”
BackgroundJeffs, B., Ito, M., Yu, R. N., Martinson, F. A., Wang, Z. J., Doglio, L. T., & Jameson, J. L. (2001) · Endocrinology · doi:10.1210/endo.142.6.8187 · Cited by 50
“Administering exogenous hCG to AHC patients produced a significant testosterone response, but did not induce spermatogenesis (13, 15).”
BackgroundSelf-citationEtiology of primary adrenal insufficiency in children: a 29-year single-center experience
Wijaya, M., Huamei, M., Jun, Z., Du, M., Li, Y., Chen, Q., Chen, H., & Song, G. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0445 · Cited by 54
Disorders of Adrenal Development
Ferraz‐de‐Souza, B., & Achermann, J. C. (2008) · KARGER eBooks · doi:10.1159/000134753 · Cited by 47
Self-citationStewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 61
Adrenal cortex and its disorders
Miller, W. L., & Flück, C. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00022-6 · Cited by 60
Bergadá, I., del Rey, G., Lapunzina, P. D., Bergadá, C., Fellous, M., & Copelli, S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1589 · Cited by 42
Tello, J. A., Newton, C. L., Bouligand, J., Guiochon‐Mantel, A., Millar, R. P., & Young, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038456 · Cited by 44
“In addition, two genes responsible for the X-linked forms of Kallmann syndrome and CHH associated with adrenal hypoplasia congenita (KAL1 and NR0B1, respectively) were also screened as previously reported [13,15].”
Stuart, A. A. V., Ozisik, G., Vroede, M. D., Giltay, J. C., Sinke, R. J., Peterson, T. J., Harris, R. M., Weiss, J., & Jameson, J. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2429 · Cited by 42
Self-citationHossain, A., Li, C., & Saunders, G. F. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0176 · Cited by 41
Genetic disorders of nuclear receptors
Achermann, J. C., Schwabe, J. W. R., Fairall, L., & Chatterjee, K. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88892 · Cited by 41
“Partial loss-of-function missense variants can be associated with a milder phenotype of delayed onset adrenal insufficiency in early adulthood, or partial hypogonadotropic hypogonadism (49).”
Self-citationRecent advances in the molecular genetics of congenital and acquired primary adrenocortical failure
Vaidya, B., Pearce, S. H. S., & Kendall‐Taylor, P. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01116.x · Cited by 40
“Rarely, AHC can present with adrenal failure later in adulthood (Tabarin et al. 2000), suggesting that AHC can not be excluded on the basis of age of onset of adrenal failure.”
BackgroundPituitary Physiology and Diagnostic Evaluation
Kaiser, U. B., & Ho, K. K. Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00008-3 · Cited by 49
Ferraz‐de‐Souza, B., Martin, F., Mallet, D., Hudson‐Davies, R. E., Cogram, P., Lin, L., Gerrelli, D., Beuschlein, F., Morel, Y., Huebner, A., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1064 · Cited by 40
Self-citationKyriakakis, N., Shonibare, T., Kyaw‐Tun, J., Lynch, J. M., Lagos, C. F., Achermann, J. C., & Murray, R. D. (2017) · Pituitary · doi:10.1007/s11102-017-0822-x · Cited by 35
“Adult presentation of patients with DAX-1 mutations likely reflects partial, rather than complete loss of repressor activity, as demonstrated in transient gene expression studies and from structural predictions [24, 27, 28].”
BackgroundSelf-citationLi, N., Liu, R., Zhang, H., Yang, J., Sun, S., Zhang, M., Liu, Y., Lü, Y., Wang, W., Mu, Y., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2408 · Cited by 34
“This promoter contains two composite SF-1/Egr-1 binding sites, which allows synergistic activation of LH gene by these transcription factors (20).”
BackgroundStyne, D. M., & Grumbach, M. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00025-0 · Cited by 43
Advances in the Molecular Genetics of Hypogonadotropic Hypergonadism
Achermann, J. C., & Jameson, J. L. (2001) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2001.14.1.3 · Cited by 33
Self-citationSalvi, R., Gómez, F., Fiaux, M., Schorderet, D. F., Jameson, J. L., Achermann, J. C., Gaillard, R. C., & Pralong, F. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011930 · Cited by 30
“Recent reports underline the importance of DAX-1 for normal human spermatogenesis (13, 24).”
BackgroundSelf-citationRaffin‐Sanson, M., Oudet, B., Salenave, S., Brailly‐Tabard, S., Pehuet, M., Christin‐Maître, S., Morel, Y., & Young, J. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-1055 · Cited by 29
The Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Self-citationAhmad, I., Paterson, W. F., Lin, L., Adlard, P., Duncan‐Flavell, P. J., Tolmie, J., Achermann, J. C., & Donaldson, M. (2007) · Hormone Research in Paediatrics · doi:10.1159/000099835 · Cited by 27
Self-citationInherited adrenal hypoplasia: not just for kids!
Lin, L., & Achermann, J. C. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.01988.x · Cited by 29
Self-citationBernard, P., Ludbrook, L. M., Queipo, G., Dinulos, M. B., Kletter, G. B., Zhang, Y., Phelan, J. K., McCabe, E. R. B., Harley, V. R., & Vilain, E. J. N. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.12.004 · Cited by 26
The genetic basis of infertility in men
Bhasin, S., Mallidis, C., & Ma, K. (2000) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2000.0085 · Cited by 26
Battle of the sexes: new insights into genetic pathways of gonadal development.
Jameson, J. L., Achermann, J. C., Özışık, G., & Meeks, J. J. (2003) · Europe PMC (PubMed Central) · Cited by 33
Self-citationBrown, P., Scobie, G. A., Townsend, J., Bayne, R. A. L., Seckl, J. R., Saunders, P. T. K., & Anderson, R. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021560 · Cited by 25
Menis, E. D., Roncaroli, F., Calvari, V., Chiarini, V., Pauletto, P., Camerino, G., & Cremonini, N. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01958 · Cited by 22
“Adrenal failure may be transient (25), asymptomatic (26) or manifest in adulthood ( 27 ).”
BackgroundKojima, Y., Sasaki, S., Hayashi, Y., Umemoto, Y., Morohashi, K., & Kohri, K. (2006) · International Journal of Urology · doi:10.1111/j.1442-2042.2006.01403.x · Cited by 26
Bergadá, I., Andreone, L., Bedecarrás, P., Ropelato, M. G., Copelli, S., Laissue, P., Rey, R. A., & Campo, S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03026.x · Cited by 22
Role of Orphan Nuclear Receptor DAX-1/NR0B1 in Development, Physiology, and Disease
Lalli, E. (2014) · Advances in Biology · doi:10.1155/2014/582749 · Cited by 25
Puberty, stress, and sudden death
Güçlü, M., Lin, L., Ertürk, E., Achermann, J. C., & Cangül, H. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61153-1 · Cited by 21
Self-citationStewart, P. M., & Newell-Price, J. D. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00015-0 · Cited by 35
Thirteen novel mutations in theNR0B1(DAX1) gene as cause of adrenal hypoplasia congenita
Krone, N. P., Riepe, F. G., Dörr, H., Morlot, M., Rudorff, K. H., Drop, S. L. S., Weigel, J. F. W., Pura, M., Kreze, A., Boronat, M., et al. (2005) · Human Mutation · doi:10.1002/humu.9331 · Cited by 20
“Several studies demonstrated that the DAX1 repression function is abolished by naturally occurring and artificial C-terminal DAX1 deletions (Altincicek, et al., 2000; Crawford, et al., 1998; Ito, et al., 1997; Lalli, et al., 1997; Reutens, et al., 1999; Tabarin, et al., 2000).”
BackgroundChoi, J., Shin, Y., Kim, G.-H., Kim, Y., Park, S., Park, J., Oh, C., & Yoo, H. (2005) · Hormone Research in Paediatrics · doi:10.1159/000085557 · Cited by 19
Mechanisms of Disease: normal and abnormal gonadal development and sex determination in mammals
Val, P., & Swain, A. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0354 · Cited by 19
“Nonetheless, this suggests that DAX1 might have a role in Sertoli-cell development and/or spermatogenesis in humans ( Table 2 )”
Okuhara, K., Shuji, A. B. E., Kondo, T., Fujita, K., Noya, K. O. D. A., Mochizuki, H., Fujieda, K., & Tajima, T. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-008 · Cited by 21
“Salt-losing adrenal insufficiency usually occurs during the neonatal period or during childhood [1, 2], although one patient with adult onset of adrenal insufficiency has been described [3].”
BackgroundTan, T. Y., Jameson, J. L., Campbell, P. E., Ekert, P. G., Zacharin, M., & Savarirayan, R. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31365 · Cited by 20
“, 1999] with symptoms of adrenal crises, but presentation in later life has been reported [Tabarin et al., 2000].”
BackgroundSelf-citationNagel, S. A., Hartmann, M. F., Riepe, F. G., Wudy, S. A., & Wabitsch, M. (2018) · Hormone Research in Paediatrics · doi:10.1159/000495189 · Cited by 18
Seminara, S. B., & Crowley, W. F. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0469 · Cited by 18
Laurenzana, E. M., Chen, T., Kannuswamy, M., Sell, B. E., Strom, S. C., Li, Y., & Omiecinski, C. J. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080721 · Cited by 19
“DAX-1 has been most clearly characterized for its role in human development, because mutations in the gene are associated with both X-linked congenital adrenal hypoplasia and hypogonadotropic hypogonadism (Zanaria et al., 1994; Tabarin et al., 2000).”
BackgroundRojek, A., Obara-Moszyńska, M., Małecka, E., Slomko-Jozwiak, M., & Niedziela, M. (2013) · Journal of Applied Genetics · doi:10.1007/s13353-013-0135-3 · Cited by 17
“These rare clinical phenotypes are due to the incomplete loss of function of NR0B1 (DAX1) mutations (Mantovani et al. 2002; Ozisik et al. 2003; Tabarin et al. 2000).”
A Novel Mutation of DAX-1 Associated with Secretory Azoospermia
Mou, L., Xie, N., Yang, L., Liu, Y., Diao, R., Cai, Z., Li, H., & Gui, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133997 · Cited by 17
Genetics and hypogonadotrophic hypogonadism
Hay, C., & Wu, F. C. W. (2002) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-200206000-00010 · Cited by 16
Suthiworachai, C., Tammachote, R., Srichomthong, C., Ittiwut, R., Suphapeetiporn, K., Sahakitrungruang, T., & Shotelersuk, V. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00270 · Cited by 16
“Some specific changes in these regions have been associated with a late-onset phenotype [9, 14, 15].”
Vargas, M. C. C., Moura, F. S., Elias, C. P., Carvalho, S. R., Rassi, N., Kunii, I. S., Dias-da-Silva, M. R., & Costa‐Barbosa, F. A. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-0500-2 · Cited by 15
Spermatogenesis and fertility outcome in male hypogonadotrophic hypogonadism
Oldereid, N. B., Åbyholm, T., & Tanbo, T. G. (2010) · Human Fertility · doi:10.3109/14647271003639723 · Cited by 14
“Due to a possible inherent defect in the gonads, these patients do not respond well to gonadotrophins or pulsatile GnRH (Mantovani et al., 2002; Tabarin et al., 2000).”
BackgroundInfluentialThe Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 35
Guidelines for diagnosis and treatment of adrenal insufficiency in adults
Novoa, P. D. M., Vela, E. T., García, N. P., Rodríguez, M. M., Guerras, I. S., Santamaría, M. D. L. Á. M. D. S., & Aulinas, A. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/s2173-5093(14)70069-8 · Cited by 16
Hypogonadisme hypogonadotrope congénital
Rozé, C., Touraine, P. A., Léger, J., & de Roux, N. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2008.06.005 · Cited by 16
DAX-1 and DAX-1A expression in human testicular tissues with primary spermatogenic failure
Lardone, M. C., Parada‐Bustamante, A., Ebensperger, M., Valdevenito, R., Kakarieka, E., Martínez, D., Pommer, R., Piottante, A., & Andrea Castro, G. (2011) · Molecular Human Reproduction · doi:10.1093/molehr/gar051 · Cited by 14
“HHG is thought to be caused by disorders at both the hypothalamic and pituitary levels (Tabarin et al., 2000); affected males, however, may have an intrinsic defect in spermatogenesis that is not responsive to gonadotropin therapy (Seminara et al.”
BackgroundLiu, Y., Li, C. G., & Zhou, S. (2009) · Drug Metabolism Letters · doi:10.2174/187231209790218145 · Cited by 14
Rarer Syndromes Characterized by Hypogonadotropic Hypogonadism
Aminzadeh, M., Kim, H., Layman, L. C., & Cheetham, T. D. (2010) · Frontiers of hormone research · doi:10.1159/000312701 · Cited by 13
Galeotti, C., Lahlou, Z., Goullon, D., Sarda-Thibault, H., Cahen-Varsaux, J., Bignon‐Topalovic, J., Bashamboo, A., McElreavey, K., & Brauner, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039828 · Cited by 14
“Tabarin et al [19] reported a man who had a AHC with an NR0B1 mutation and with a delayed-onset primary insufficiency in adulthood and an incomplete HH.”
BackgroundSibling Cases of Addison's Disease Caused byDAX-1 Gene Mutations
Sekiguchi, Y., Hara, Y., Matsuoka, H., Hayashi, Y., Katsumata, N., & Hirata, Y. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.6082 · Cited by 13
Brain nuclear receptors and cardiovascular function
Wang, M., Yang, Y., & Xu, Y. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00962-3 · Cited by 13
Laissue, P., Copelli, S., Bergadá, I., Bergadá, C., Barrio, G., Karaboga, S., Wurtz, J., Fellous, M., Lalli, E., & Veitia, R. A. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02649.x · Cited by 12
Late-onset adrenal hypoplasia congenita caused by a novel mutation of the DAX-1 gene
Yang, F., Hanaki, K., Kinoshita, T., Kawashima, Y., Nagaishi, J.-I., & Kanzaki, S. (2008) · European Journal of Pediatrics · doi:10.1007/s00431-008-0779-x · Cited by 12
“Another patient who presented with mild adrenal failure at 28 years of age had an I439S missense mutation [8].”
BackgroundVulnerability within a Robust Complex System--DAX-1 Mutations and Steroidogenic Axis Development
McCabe, E. R. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.1.41 · Cited by 12
Metadata
- Authors
- Tabarin, A., Achermann, J. C., Recan, D., Bex, V., Bertagna, X., Christin-Maitre, S., Ito, M., Jameson, J. L., & Bouchard, P.
- Affiliations
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Northwestern University (US)
- Hôpital Cochin (FR)
- Hôpital Saint-Antoine (FR)
- Corresponding author
- Tabarin, Antoine
- Venue
- Journal of Clinical Investigation
- Published
- 2000-02-01
- Volume
- 105
- Issue
- 3
- Pages
- 321-328
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC377437
- OpenAlex
- W2168933737
- Cited by
- 187
- References
- 59
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 5 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 8 · 2018: 7 · 2017: 5 · 2016: 6 · 2015: 4 · 2014: 7 · 2013: 5 · 2012: 5
- FWCI
- 10.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institutes of Health
- National Center for Research Resources (MO1-RR-00048, M01RR000048)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD29164, U54HD029164)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Keywords
- DAX-1, NR0B1, X-linked adrenal hypoplasia congenita, spermatogenesis, oligozoospermia, pubertal development, clinical phenotype spectrum
- MeSH terms
- Adrenal Glands, Adult, Animals, DNA-Binding Proteins, Humans, Hypogonadism, Male, Mutation, Repressor Proteins, Transcription Factors, Age of Onset, Receptors, Retinoic Acid, Mice, Knockout, Mice, DAX-1 Orphan Nuclear Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.